|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01513 LIVZON PHARMA
Nominal 
37.280 -1.000 (-2.612%) Non-current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 9,505 | -4.236% | 9,926 | 10,767 | 0 | 0 |
| Property, plant, equip. & others | 4,409,762 | -2.270% | 4,512,172 | 4,583,539 | 4,570,057 | 4,224,304 |
| Land & other Lease Assets | 306,265 | 42.476% | 214,958 | 219,857 | 224,304 | 194,166 |
| Intangible Assets | 337,810 | -0.268% | 338,718 | 352,245 | 458,002 | 183,742 |
| Interests in Asso. & JCEs | 1,075,562 | 1.831% | 1,056,220 | 1,031,260 | 1,055,939 | 1,064,968 |
| Other Non-current Assets | 1,795,788 | -5.676% | 1,903,851 | 1,580,984 | 1,572,570 | 2,031,639 |
| 7,934,692 | -1.259% | 8,035,845 | 7,778,652 | 7,880,872 | 7,698,819 | |
Current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 1,714,611 | -14.168% | 1,997,642 | 2,060,651 | 2,045,342 | 1,663,228 | |
| Trade Receivables | 3,445,018 | 6.030% | 3,249,107 | 3,574,992 | 4,039,196 | 3,293,927 | |
| Cash & Bank Balances | 10,352,468 | -4.384% | 10,827,147 | 11,325,724 | 10,411,348 | 9,146,373 | |
| Other Current Assets | 726,080 | 109.799% | 346,085 | 304,808 | 491,411 | 569,568 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 16,238,178 | -1.107% | 16,419,981 | 17,266,175 | 16,987,297 | 14,673,097 | ||
Current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 1,390,220 | -12.232% | 1,583,979 | 1,658,413 | 1,862,022 | 1,817,300 | ||
| S-T Debt & Leases | 2,236,811 | -10.661% | 2,503,742 | 2,519,689 | 1,632,681 | 2,052,332 | ||
| Other Current Liabilities | 3,782,706 | 6.925% | 3,537,708 | 3,909,035 | 3,901,962 | 3,055,436 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 7,409,737 | -2.829% | 7,625,428 | 8,087,137 | 7,396,665 | 6,925,068 | |||
| Net Current Assets | 8,828,440 | 0.385% | 8,794,552 | 9,179,037 | 9,590,632 | 7,748,029 | ||
| Total Assets Less Current Liabilities | 16,763,133 | -0.400% | 16,830,397 | 16,957,690 | 17,471,504 | 15,446,848 | ||
Non-current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 1,382,739 | -6.498% | 1,478,838 | 1,621,804 | 1,986,052 | 642,054 | |||
| Other Non-current Liabilities | 456,205 | 2.331% | 445,813 | 569,183 | 549,168 | 493,768 | |||
| 1,838,944 | -4.453% | 1,924,651 | 2,190,987 | 2,535,220 | 1,135,823 | ||||
Capital and Reserves
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 904,100 | -0.795% | 911,346 | 923,938 | 935,553 | 937,865 | ||||
| Reserves | 12,773,603 | -1.370% | 12,950,988 | 13,118,557 | 12,940,517 | 12,065,899 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 13,677,704 | -1.332% | 13,862,334 | 14,042,495 | 13,876,069 | 13,003,764 | ||||
| Non-controlling Interests | 1,246,485 | 19.462% | 1,043,412 | 724,208 | 1,060,215 | 1,307,261 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 14,924,188 | 0.124% | 14,905,747 | 14,766,703 | 14,936,284 | 14,311,025 | |||||
Commitments and Contingent Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 447,814 | 709,927 | 406,786 | 886,353 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 22/08/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,281,088 |
| %Change | 9.404% |
| EPS / (LPS) | RMB 1.430 |
| NBV Per Share (¥) | RMB 15.129 |